Omics Based Clinical Trials Market, Global Outlook and Forecast 2022-2028

April 2022 | 67 pages | ID: O465FF1C961BEN
Market Monitor Global

Abstracts

Omics is a rapidly evolving, multi-disciplinary, and emerging field that encompasses genomics, epigenomics, transcriptomics, proteomics, and metabolomics.Advanced omics technologies, including single-cell omics and multi-omics, are being used to evaluate a variety of cancer immunotherapies. Furthermore, given the precision medicine environment, the expanding use of multi-omics in research, as well as the penetration of contemporary sequencing technologies, is boosting the market.

This report contains market size and forecasts of Omics Based Clinical Trials in Global, including the following market information:

Global Omics Based Clinical Trials Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Omics Based Clinical Trials market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Interventional Studies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Omics Based Clinical Trials include Parexel International Corporation, Pharmaceutical Product Development (PPD), Charles River Laboratory, ICON plc, SGS SA, Eli Lilly and Company, Pfizer, Covance and Rebus Bio and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Omics Based Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Omics Based Clinical Trials Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Omics Based Clinical Trials Market Segment Percentages, by Type, 2021 (%)

• Interventional Studies
• Observational Studies
• Expanded Access Studies

Global Omics Based Clinical Trials Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Omics Based Clinical Trials Market Segment Percentages, by Application, 2021 (%)

• Oncology
• Cardiology
• Respiratory Diseases
• Skin Diseases
• CNS Diseases
• Immunology
• Genetic Diseases
• Other Indications

Global Omics Based Clinical Trials Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Omics Based Clinical Trials Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Omics Based Clinical Trials revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Omics Based Clinical Trials revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Parexel International Corporation
• Pharmaceutical Product Development (PPD)
• Charles River Laboratory
• ICON plc
• SGS SA
• Eli Lilly and Company
• Pfizer
• Covance
• Rebus Bio
• Novo Nordisk

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Omics Based Clinical Trials Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Omics Based Clinical Trials Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OMICS BASED CLINICAL TRIALS OVERALL MARKET SIZE

2.1 Global Omics Based Clinical Trials Market Size: 2021 VS 2028
2.2 Global Omics Based Clinical Trials Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Omics Based Clinical Trials Players in Global Market
3.2 Top Global Omics Based Clinical Trials Companies Ranked by Revenue
3.3 Global Omics Based Clinical Trials Revenue by Companies
3.4 Top 3 and Top 5 Omics Based Clinical Trials Companies in Global Market, by Revenue in 2021
3.5 Global Companies Omics Based Clinical Trials Product Type
3.6 Tier 1, Tier 2 and Tier 3 Omics Based Clinical Trials Players in Global Market
  3.6.1 List of Global Tier 1 Omics Based Clinical Trials Companies
  3.6.2 List of Global Tier 2 and Tier 3 Omics Based Clinical Trials Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Omics Based Clinical Trials Market Size Markets, 2021 & 2028
  4.1.2 Interventional Studies
  4.1.3 Observational Studies
  4.1.4 Expanded Access Studies
4.2 By Type - Global Omics Based Clinical Trials Revenue & Forecasts
  4.2.1 By Type - Global Omics Based Clinical Trials Revenue, 2017-2022
  4.2.2 By Type - Global Omics Based Clinical Trials Revenue, 2023-2028
  4.2.3 By Type - Global Omics Based Clinical Trials Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Omics Based Clinical Trials Market Size, 2021 & 2028
  5.1.2 Oncology
  5.1.3 Cardiology
  5.1.4 Respiratory Diseases
  5.1.5 Skin Diseases
  5.1.6 CNS Diseases
  5.1.7 Immunology
  5.1.8 Genetic Diseases
  5.1.9 Other Indications
5.2 By Application - Global Omics Based Clinical Trials Revenue & Forecasts
  5.2.1 By Application - Global Omics Based Clinical Trials Revenue, 2017-2022
  5.2.2 By Application - Global Omics Based Clinical Trials Revenue, 2023-2028
  5.2.3 By Application - Global Omics Based Clinical Trials Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Omics Based Clinical Trials Market Size, 2021 & 2028
6.2 By Region - Global Omics Based Clinical Trials Revenue & Forecasts
  6.2.1 By Region - Global Omics Based Clinical Trials Revenue, 2017-2022
  6.2.2 By Region - Global Omics Based Clinical Trials Revenue, 2023-2028
  6.2.3 By Region - Global Omics Based Clinical Trials Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Omics Based Clinical Trials Revenue, 2017-2028
  6.3.2 US Omics Based Clinical Trials Market Size, 2017-2028
  6.3.3 Canada Omics Based Clinical Trials Market Size, 2017-2028
  6.3.4 Mexico Omics Based Clinical Trials Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Omics Based Clinical Trials Revenue, 2017-2028
  6.4.2 Germany Omics Based Clinical Trials Market Size, 2017-2028
  6.4.3 France Omics Based Clinical Trials Market Size, 2017-2028
  6.4.4 U.K. Omics Based Clinical Trials Market Size, 2017-2028
  6.4.5 Italy Omics Based Clinical Trials Market Size, 2017-2028
  6.4.6 Russia Omics Based Clinical Trials Market Size, 2017-2028
  6.4.7 Nordic Countries Omics Based Clinical Trials Market Size, 2017-2028
  6.4.8 Benelux Omics Based Clinical Trials Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Omics Based Clinical Trials Revenue, 2017-2028
  6.5.2 China Omics Based Clinical Trials Market Size, 2017-2028
  6.5.3 Japan Omics Based Clinical Trials Market Size, 2017-2028
  6.5.4 South Korea Omics Based Clinical Trials Market Size, 2017-2028
  6.5.5 Southeast Asia Omics Based Clinical Trials Market Size, 2017-2028
  6.5.6 India Omics Based Clinical Trials Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Omics Based Clinical Trials Revenue, 2017-2028
  6.6.2 Brazil Omics Based Clinical Trials Market Size, 2017-2028
  6.6.3 Argentina Omics Based Clinical Trials Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Omics Based Clinical Trials Revenue, 2017-2028
  6.7.2 Turkey Omics Based Clinical Trials Market Size, 2017-2028
  6.7.3 Israel Omics Based Clinical Trials Market Size, 2017-2028
  6.7.4 Saudi Arabia Omics Based Clinical Trials Market Size, 2017-2028
  6.7.5 UAE Omics Based Clinical Trials Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Parexel International Corporation
  7.1.1 Parexel International Corporation Corporate Summary
  7.1.2 Parexel International Corporation Business Overview
  7.1.3 Parexel International Corporation Omics Based Clinical Trials Major Product Offerings
  7.1.4 Parexel International Corporation Omics Based Clinical Trials Revenue in Global Market (2017-2022)
  7.1.5 Parexel International Corporation Key News
7.2 Pharmaceutical Product Development (PPD)
  7.2.1 Pharmaceutical Product Development (PPD) Corporate Summary
  7.2.2 Pharmaceutical Product Development (PPD) Business Overview
  7.2.3 Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Major Product Offerings
  7.2.4 Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Revenue in Global Market (2017-2022)
  7.2.5 Pharmaceutical Product Development (PPD) Key News
7.3 Charles River Laboratory
  7.3.1 Charles River Laboratory Corporate Summary
  7.3.2 Charles River Laboratory Business Overview
  7.3.3 Charles River Laboratory Omics Based Clinical Trials Major Product Offerings
  7.3.4 Charles River Laboratory Omics Based Clinical Trials Revenue in Global Market (2017-2022)
  7.3.5 Charles River Laboratory Key News
7.4 ICON plc
  7.4.1 ICON plc Corporate Summary
  7.4.2 ICON plc Business Overview
  7.4.3 ICON plc Omics Based Clinical Trials Major Product Offerings
  7.4.4 ICON plc Omics Based Clinical Trials Revenue in Global Market (2017-2022)
  7.4.5 ICON plc Key News
7.5 SGS SA
  7.5.1 SGS SA Corporate Summary
  7.5.2 SGS SA Business Overview
  7.5.3 SGS SA Omics Based Clinical Trials Major Product Offerings
  7.5.4 SGS SA Omics Based Clinical Trials Revenue in Global Market (2017-2022)
  7.5.5 SGS SA Key News
7.6 Eli Lilly and Company
  7.6.1 Eli Lilly and Company Corporate Summary
  7.6.2 Eli Lilly and Company Business Overview
  7.6.3 Eli Lilly and Company Omics Based Clinical Trials Major Product Offerings
  7.6.4 Eli Lilly and Company Omics Based Clinical Trials Revenue in Global Market (2017-2022)
  7.6.5 Eli Lilly and Company Key News
7.7 Pfizer
  7.7.1 Pfizer Corporate Summary
  7.7.2 Pfizer Business Overview
  7.7.3 Pfizer Omics Based Clinical Trials Major Product Offerings
  7.7.4 Pfizer Omics Based Clinical Trials Revenue in Global Market (2017-2022)
  7.7.5 Pfizer Key News
7.8 Covance
  7.8.1 Covance Corporate Summary
  7.8.2 Covance Business Overview
  7.8.3 Covance Omics Based Clinical Trials Major Product Offerings
  7.8.4 Covance Omics Based Clinical Trials Revenue in Global Market (2017-2022)
  7.8.5 Covance Key News
7.9 Rebus Bio
  7.9.1 Rebus Bio Corporate Summary
  7.9.2 Rebus Bio Business Overview
  7.9.3 Rebus Bio Omics Based Clinical Trials Major Product Offerings
  7.9.4 Rebus Bio Omics Based Clinical Trials Revenue in Global Market (2017-2022)
  7.9.5 Rebus Bio Key News
7.10 Novo Nordisk
  7.10.1 Novo Nordisk Corporate Summary
  7.10.2 Novo Nordisk Business Overview
  7.10.3 Novo Nordisk Omics Based Clinical Trials Major Product Offerings
  7.10.4 Novo Nordisk Omics Based Clinical Trials Revenue in Global Market (2017-2022)
  7.10.5 Novo Nordisk Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Omics Based Clinical Trials Market Opportunities & Trends in Global Market
Table 2. Omics Based Clinical Trials Market Drivers in Global Market
Table 3. Omics Based Clinical Trials Market Restraints in Global Market
Table 4. Key Players of Omics Based Clinical Trials in Global Market
Table 5. Top Omics Based Clinical Trials Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Omics Based Clinical Trials Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Omics Based Clinical Trials Revenue Share by Companies, 2017-2022
Table 8. Global Companies Omics Based Clinical Trials Product Type
Table 9. List of Global Tier 1 Omics Based Clinical Trials Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Omics Based Clinical Trials Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Omics Based Clinical Trials Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Omics Based Clinical Trials Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Omics Based Clinical Trials Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Omics Based Clinical Trials Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Omics Based Clinical Trials Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Omics Based Clinical Trials Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Omics Based Clinical Trials Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Omics Based Clinical Trials Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Omics Based Clinical Trials Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Omics Based Clinical Trials Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Omics Based Clinical Trials Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Omics Based Clinical Trials Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Omics Based Clinical Trials Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Omics Based Clinical Trials Revenue, (US$, Mn), 2023-2028
Table 30. Parexel International Corporation Corporate Summary
Table 31. Parexel International Corporation Omics Based Clinical Trials Product Offerings
Table 32. Parexel International Corporation Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 33. Pharmaceutical Product Development (PPD) Corporate Summary
Table 34. Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Product Offerings
Table 35. Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 36. Charles River Laboratory Corporate Summary
Table 37. Charles River Laboratory Omics Based Clinical Trials Product Offerings
Table 38. Charles River Laboratory Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 39. ICON plc Corporate Summary
Table 40. ICON plc Omics Based Clinical Trials Product Offerings
Table 41. ICON plc Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 42. SGS SA Corporate Summary
Table 43. SGS SA Omics Based Clinical Trials Product Offerings
Table 44. SGS SA Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 45. Eli Lilly and Company Corporate Summary
Table 46. Eli Lilly and Company Omics Based Clinical Trials Product Offerings
Table 47. Eli Lilly and Company Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Omics Based Clinical Trials Product Offerings
Table 50. Pfizer Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 51. Covance Corporate Summary
Table 52. Covance Omics Based Clinical Trials Product Offerings
Table 53. Covance Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 54. Rebus Bio Corporate Summary
Table 55. Rebus Bio Omics Based Clinical Trials Product Offerings
Table 56. Rebus Bio Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 57. Novo Nordisk Corporate Summary
Table 58. Novo Nordisk Omics Based Clinical Trials Product Offerings
Table 59. Novo Nordisk Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Omics Based Clinical Trials Segment by Type in 2021
Figure 2. Omics Based Clinical Trials Segment by Application in 2021
Figure 3. Global Omics Based Clinical Trials Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Omics Based Clinical Trials Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Omics Based Clinical Trials Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Omics Based Clinical Trials Revenue in 2021
Figure 8. By Type - Global Omics Based Clinical Trials Revenue Market Share, 2017-2028
Figure 9. By Application - Global Omics Based Clinical Trials Revenue Market Share, 2017-2028
Figure 10. By Region - Global Omics Based Clinical Trials Revenue Market Share, 2017-2028
Figure 11. By Country - North America Omics Based Clinical Trials Revenue Market Share, 2017-2028
Figure 12. US Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Omics Based Clinical Trials Revenue Market Share, 2017-2028
Figure 16. Germany Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 17. France Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Omics Based Clinical Trials Revenue Market Share, 2017-2028
Figure 24. China Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 28. India Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Omics Based Clinical Trials Revenue Market Share, 2017-2028
Figure 30. Brazil Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Omics Based Clinical Trials Revenue Market Share, 2017-2028
Figure 33. Turkey Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 37. Parexel International Corporation Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Charles River Laboratory Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. ICON plc Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. SGS SA Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Eli Lilly and Company Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Covance Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Rebus Bio Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Novo Nordisk Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)